Evolution of the Average Target: Canal+ SA

Data source: Canal+ SA(CAN)

Evolution of the Target Price: Canal+ SA

Data source: Canal+ SA(CAN)

Changes in Analyst Recommendations: Canal+ SA

Data source: Canal+ SA(CAN)
b35b1bfa7e17997390c6d.dHG48ABcR5lRScF7a4SkdkiPxEXJyQm2j-WIk2iB4Kk.DjiKomQTcNQ4IvYaJbT2Enuipy28sG_T29fdoAn0hfwbXNu1QgYh8x8oog~41672c7e8effebd290435e8cac0dc961
09-08 Jefferies raises Autotrader and Rightmove AN
07-28 Canal+: A very reassuring H1, both for the historical perimeter and for MultiChoice. Alphavalue
06-30 BofA: Canal+ H1 Results to Focus on Turnaround Progress at MultiChoice; Buy Rating Affirmed MT
04-28 Canal Keeps Momentum in the First Quarter Zonebourse
04-28 Canal+: Rather reassuring Q1, although it's still too early to assess MultiChoice's recovery Alphavalue
04-23 Canal+: Consolidation of MultiChoice Alphavalue
03-11 Canal+: Long way to go before turning around MultiChoice Alphavalue
02-02 Jefferies cuts BAE; Citi raises Anglo American AN
01-30 UBS cuts Antofagasta and Eurowag AN
01-06 BofA Raises Canal+ PT, Retains Buy Rating MT
01-06 RBC raises Diageo; BofA cuts JD Sports Fashion AN
01-06 Canal+ VAT Dispute Settlement Prompts BofA to Lift Price Target MT
01-05 Bank of America raises its price target on Canal+ Zonebourse
11-27 UBS cuts SSE; Citi lifts Compass AN
16/10/25 Canal+: A reassuring Q3 while patiently awaiting the future Multichoice development plan Alphavalue
16/10/25 Canal+ reports 9-month revenue in line with guidance RE
29/07/25 Canal+: Revenue growth lacks momentum, but the EBIT margin is reassuring. Alphavalue
04/07/25 Canal+: Deutsche Bank still a buyer, raises target price Zonebourse
29/04/25 Canal+: A Q1 without surprises and still concerns about MultiChoice's acquisition Alphavalue
14/03/25 Deutsche Bank Starts Canal+ SA Coverage at Buy MT
14/03/25 Canal+: Deutsche Bank initiates buy coverage Zonebourse
04/03/25 Canal+: We have decided to apply a discount to the valuation of Multichoice Alphavalue
14/01/25 HSBC Kicks Off Canal+ Coverage at Buy MT
07/01/25 BNP Paribas Exane Begins Canal+ Coverage at Outperform MT
20/12/24 Canal+: UBS is Neutral on the stock, target 240p Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+20.7%
+21.98%
+29.11%
+13.79%
+52.72%
+18.43%
+40.6%
- - - -7.94%
+29.7%
Average +24.34%
Weighted average by Cap. +22.01%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
2.108GBP
Average target price
3.511GBP
Spread / Average Target
+66.56%
High Price Target
5.200GBP
Spread / Highest target
+146.68%
Low Price Target
2.250GBP
Spread / Lowest Target
+6.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB